Internal Medicine Alert - September 30, 2012

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/12. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty Listing:

Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
Jeff Unger, MD
Director, Metabolic Studies
Catalina Research Institute
Chino, CA

Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor,
West Virginia University School of Medicine
Charleston, WV

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Author
Richard R. Watkins, MD, MS, FACP
Division of Infectious Diseases
Akron General Medical Center
Akron, OH;
Associate Professor of Internal Medicine
Northeast Ohio Medical University
Rootstown, OH

Subjects:

  • Optimal Management for Obese Patients with Type 2 Diabetes: Surgery vs Medical Therapy
  • Risk of Falls and Major Bleeds when on Oral Anticoagulants
  • Improvement in Primary Prevention of Cardiovascular Disease Using Novel Risk Markers
  • Herpes Zoster Vaccine and the Incidence of Recurrent Herpes Zoster in the Elderly
  • Pharmacology Update: Linaclotide Capsules (Linzess®)
  • Could Thinner be Worse for Newly Diagnosed Diabetics?
  • The Impact of Exercise on Depression in Heart Failure
  • Reversible Dementia from Corticosteroid Therapy

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Lilly, Boehringer Ingelheim, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Lilly, Kowa, Novo Nordisk, and Teva.

Associate editors Jeff Unger, MD, Rahul Gupta, MD, MPH, FACP, Harold L. Karpman, MD, FACC, FACP, William T. Elliott, MD, FACP, , and James Chan, PharmD, PhD, Author Richard R. Watkins, MD, MS, FACP, Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda.

Copyright 2012 AHC Media. All rights reserved.